This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (24)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Surgical Cytokines  • Alert me on articles by topic  Social Bookmarking   What's this?

Martin C. Robson, MD; Donald P. Hill, PharmD; Matthew E. Woodske, BS; David L. Steed, MD

Arch Surg. 2000;135:773-777.

Background  One goal of wound healing research is to discover agents to accelerate healing. Regulatory agencies have suggested stringent criteria to determine efficacy, that of 100% wound closure. Data analysis at a single point such as 100% closure does not provide detailed information about agent effectiveness over the entire span of healing.

Hypothesis  Wound healing trajectories can provide such information and can be used to demonstrate utility as alternative end points for wound healing trials.

Design  Data from 160 patients in 11 clinical trials of diabetic foot ulcers conducted at 2 centers were evaluated. Wound healing trajectories were constructed for patients whose wounds healed (100% closure) and those whose did not (<100% closure) over a 20-week period. The percentage of patients achieving total healing vs time of treatment was plotted and divided into patients receiving a test agent or placebo.

Results  The healing trajectories were almost identical for patients achieving complete healing at the 2 centers, as were the trajectories for patients with less than 100% closure. However, the trajectories of patients achieving total healing were significantly different from those not achieving 100% closure. Fifty-two percent of all patients achieved 100% healing by 20 weeks; 61% of patients receiving an experimental agent had total healing compared with 39% of placebo-treated patients. Linear regression suggested that all patients would achieve total healing by 37 weeks.

Conclusions  Since wound healing trajectories for diabetic foot ulcers treated at 2 centers so closely mimic one another, trajectories might be useful efficacy end points, and used to compare significant points along a continuum rather than a single static end point. Shifting of the wound healing trajectory from an impaired to a more ideal course may be considered when determining efficacy of new wound treatments.

From the Department of Surgery, University of South Florida, Tampa, and Institute for Tissue Regeneration, Repair, and Rehabilitation, Bay Pines Veterans Affairs Medical Center, Bay Pines, Fla (Drs Robson and Hill); and the Department of Surgery, University of Pittsburgh, Pittsburgh, Pa (Mr Woodske and Dr Steed).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(7):877-878.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Percent Change in Wound Area of Diabetic Foot Ulcers Over a 4-Week Period Is a Robust Predictor of Complete Healing in a 12-Week Prospective Trial
Sheehan et al.
Diabetes Care 2003;26:1879-1882.
ABSTRACT | FULL TEXT  

The Use of Laser Doppler Imaging in Measuring Wound-Healing Progress
Blot et al.
Arch Surg 2001;136:116-116.
FULL TEXT